Post-Bacille Calmette–Guerin surveillance for non-muscle invasive bladder cancer: do random biopsies offer an advantage?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1961-9987
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Post-Bacille Calmette–Guerin surveillance for non-muscle invasive bladder cancer: do random biopsies offer an advantage? ; volume:27 ; number:1 ; day:17 ; month:3 ; year:2021 ; pages:1-6 ; date:12.2021
African journal of urology ; 27, Heft 1 (17.3.2021), 1-6, 12.2021
- Urheber
-
Abou Heidar, Nassib
Labban, Muhieddine Saadeddine
Armache, Alexandre Khalil
Bulbul, Muhammad Ahmad
El-Hajj, Albert Elias
Khauli, Raja Bahjat
Nasr, Rami
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12301-021-00151-z
- URN
-
urn:nbn:de:101:1-2021050420270923761288
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
05.09.2002, 22:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Abou Heidar, Nassib
- Labban, Muhieddine Saadeddine
- Armache, Alexandre Khalil
- Bulbul, Muhammad Ahmad
- El-Hajj, Albert Elias
- Khauli, Raja Bahjat
- Nasr, Rami
- SpringerLink (Online service)
Ähnliche Objekte (12)
Nonmuscle invasive urothelial cancer— Bacillus Calmette–Guérin instillation or checkpoint inhibitor immunotherapy?
Durch Bacillus Calmette-Guerin induzierte Tuberkulose
Assessing treatment response after intravesical bacillus Calmette–Guerin induction cycle: are routine bladder biopsies necessary?
Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use
Elicitation of Health State Utilities Associated with Progression from Bacillus Calmette-Guerin (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC)
Correction to: Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use
Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: a Markov model
Bekämpfung der Tuberkulose: Schutzimpfung mit Bacillus Calmette-Guérin (BCG)
Die intravesikale Immuntherapie mit Bacillus Calmette-Guérin : Fakten, Vergleiche, Ergebnisse
Measles infection causing Bacillus Calmette-Guérin reactivation: a case report
Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency
Bacille Calmette-Guérin Supply Disruption Emphasizes the Importance of Stewardship
Nonmuscle invasive urothelial cancer— Bacillus Calmette–Guérin instillation or checkpoint inhibitor immunotherapy?
Durch Bacillus Calmette-Guerin induzierte Tuberkulose
Assessing treatment response after intravesical bacillus Calmette–Guerin induction cycle: are routine bladder biopsies necessary?
Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use
Elicitation of Health State Utilities Associated with Progression from Bacillus Calmette-Guerin (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC)
Correction to: Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use
Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: a Markov model
Bekämpfung der Tuberkulose: Schutzimpfung mit Bacillus Calmette-Guérin (BCG)
Die intravesikale Immuntherapie mit Bacillus Calmette-Guérin : Fakten, Vergleiche, Ergebnisse
Measles infection causing Bacillus Calmette-Guérin reactivation: a case report
Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency
Bacille Calmette-Guérin Supply Disruption Emphasizes the Importance of Stewardship
Nonmuscle invasive urothelial cancer— Bacillus Calmette–Guérin instillation or checkpoint inhibitor immunotherapy?
Durch Bacillus Calmette-Guerin induzierte Tuberkulose
Assessing treatment response after intravesical bacillus Calmette–Guerin induction cycle: are routine bladder biopsies necessary?
Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use
Elicitation of Health State Utilities Associated with Progression from Bacillus Calmette-Guerin (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC)
Correction to: Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use
Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: a Markov model
Bekämpfung der Tuberkulose: Schutzimpfung mit Bacillus Calmette-Guérin (BCG)
Die intravesikale Immuntherapie mit Bacillus Calmette-Guérin : Fakten, Vergleiche, Ergebnisse
Measles infection causing Bacillus Calmette-Guérin reactivation: a case report
Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency